Insights

Strategic Partnerships Kiniksa Pharmaceuticals has a track record of forming strategic partnerships with key players in the industry, such as Roche and Genentech. Leveraging these collaborations can lead to new sales opportunities and market access.

Clinical Breakthroughs The development of innovative drugs like mavrilimumab and vixarelimab showcases Kiniksa's commitment to clinical breakthroughs. Highlighting the superior efficacy of these drugs compared to standard therapies can attract interest from healthcare providers seeking cutting-edge solutions.

Market Expansion Recent expansions into new markets, such as the Asia-Pacific region through deals with Huadong Medicine Co. Ltd., present avenues for market expansion and potential sales growth. Exploring these regions can open doors to new customer bases and revenue streams.

Employee Expertise Kiniksa prioritizes hiring and retaining highly skilled employees across various departments. Engaging with their team of experts in research, development, and commercialization can provide valuable insights and opportunities to tailor solutions that meet specific market needs.

Competitive Positioning By positioning themselves as a leader in immunological therapies, Kiniksa Pharmaceuticals establishes a competitive edge that can be leveraged for sales. Highlighting their expertise in modulating immunological pathways can attract partners and customers looking for advanced treatment options.

Kiniksa Pharmaceuticals Tech Stack

Kiniksa Pharmaceuticals uses 8 technology products and services including Bill.com, SAS/GRAPH, Genesys, and more. Explore Kiniksa Pharmaceuticals's tech stack below.

  • Bill.com
    Accounting And Finance
  • SAS/GRAPH
    Business Intelligence
  • Genesys
    Customer Experience Management
  • Microsoft 365
    Email
  • Modernizr
    Javascript Libraries
  • Marketo
    Marketing Automation
  • Akamai Bot Manager
    Security
  • Matillion
    Tag Management

Media & News

Kiniksa Pharmaceuticals's Email Address Formats

Kiniksa Pharmaceuticals uses at least 1 format(s):
Kiniksa Pharmaceuticals Email FormatsExamplePercentage
FLast@kiniksa.comJDoe@kiniksa.com
87%
Last@kiniksa.comDoe@kiniksa.com
6%
LFirst@kiniksa.comDJohn@kiniksa.com
4%
F.Last@kiniksa.comJ.Doe@kiniksa.com
3%

Frequently Asked Questions

Where is Kiniksa Pharmaceuticals's headquarters located?

Minus sign iconPlus sign icon
Kiniksa Pharmaceuticals's main headquarters is located at 100 Hayden Ave Lexington, Massachusetts 02421 US. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is Kiniksa Pharmaceuticals's stock symbol?

Minus sign iconPlus sign icon
Kiniksa Pharmaceuticals is a publicly traded company; the company's stock symbol is KNSA.

What is Kiniksa Pharmaceuticals's official website and social media links?

Minus sign iconPlus sign icon
Kiniksa Pharmaceuticals's official website is kiniksa.com and has social profiles on LinkedIn.

How much revenue does Kiniksa Pharmaceuticals generate?

Minus sign iconPlus sign icon
As of October 2024, Kiniksa Pharmaceuticals's annual revenue reached $75M.

What is Kiniksa Pharmaceuticals's SIC code NAICS code?

Minus sign iconPlus sign icon
Kiniksa Pharmaceuticals's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Kiniksa Pharmaceuticals have currently?

Minus sign iconPlus sign icon
As of October 2024, Kiniksa Pharmaceuticals has approximately 322 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: S. P.Chief Operating Officer: E. T.Chief Financial Officer: C. H.. Explore Kiniksa Pharmaceuticals's employee directory with LeadIQ.

What industry does Kiniksa Pharmaceuticals belong to?

Minus sign iconPlus sign icon
Kiniksa Pharmaceuticals operates in the Biotechnology Research industry.

What technology does Kiniksa Pharmaceuticals use?

Minus sign iconPlus sign icon
Kiniksa Pharmaceuticals's tech stack includes Bill.comSAS/GRAPHGenesysMicrosoft 365ModernizrMarketoAkamai Bot ManagerMatillion.

What is Kiniksa Pharmaceuticals's email format?

Minus sign iconPlus sign icon
Kiniksa Pharmaceuticals's email format typically follows the pattern of . Find more Kiniksa Pharmaceuticals email formats with LeadIQ.

How much funding has Kiniksa Pharmaceuticals raised to date?

Minus sign iconPlus sign icon
As of October 2024, Kiniksa Pharmaceuticals has raised $80M in funding. The last funding round occurred on May 13, 2020 for $80M.

When was Kiniksa Pharmaceuticals founded?

Minus sign iconPlus sign icon
Kiniksa Pharmaceuticals was founded in 2015.
Kiniksa Pharmaceuticals

Kiniksa Pharmaceuticals

Biotechnology ResearchMassachusetts, United States201-500 Employees

Kiniksa is a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need.  

We have an experienced team that has advanced multiple product candidates in parallel that focus on a range of debilitating diseases with significant unmet medical need. We continue to explore expanding our pipeline in order to develop life-changing medicines for patients who need it most.

We are focused on hiring and retaining a highly skilled team that has extensive experience and specific skill sets relating to the selection, development, and commercialization of transformative therapies. Whether in development, research, manufacturing, technical operations, or general / administrative functions, we depend on a brilliant team to support our mission of building a global, generational company. 

Our benefits are competitive, and we offer dynamic career opportunities across our organization fostering a culture that embraces passion and rapid execution.

Section iconCompany Overview

Headquarters
100 Hayden Ave Lexington, Massachusetts 02421 US
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
KNSA
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
201-500

Section iconFunding & Financials

  • $80M

    Kiniksa Pharmaceuticals has raised a total of $80M of funding over 4 rounds. Their latest funding round was raised on May 13, 2020 in the amount of $80M.

  • $50M$100M

    Kiniksa Pharmaceuticals's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $80M

    Kiniksa Pharmaceuticals has raised a total of $80M of funding over 4 rounds. Their latest funding round was raised on May 13, 2020 in the amount of $80M.

  • $50M$100M

    Kiniksa Pharmaceuticals's revenue is in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.